Page 6 - Genome Sciences News Today

The University of Maryland, Baltimore (UMB) is the state’s public health, law, and human services university devoted to excellence in professional and graduate education, research, patient care, and public service.

STEM and minorities   An event for Lesbian, Gay, Bisexual, Transgender, and Queer (LGBTQ) youth and scientists in the Mütter Museum’s [...]

Gut bacteria can influence brain health, according to a study of mice genetically predisposed to develop Alzheimer’s-like brain damage. The Washington University School of Medicine in St. Louis study findings suggest a new approach to treating Alzheimer’s and other neurodegenerative diseases.

A growing pile of evidence indicates that the tens of trillions of microbes that normally live in our intestines -; the so-called gut microbiome -; have far-reaching effects on how our bodies function.

Gut bacteria affect the behavior of immune cells throughout the body and in the brain, including ones implicated in neurodegenerative disorders such as Alzheimer's disease. The findings open up the possibility of altering the microbiome to prevent or treat neurodegeneration.

Seres Therapeutics Appoints Genomic Medicine and Microbiology Pioneer Claire M. Fraser, Ph.D., to its Board of Directors and Announces SER-155 Phase 1b Study Progress - read this article along with other careers information, tips and advice on BioSpace

/PRNewswire/ -- The Galien Foundation today announced the appointment of Michael Rosenblatt, M.D., as Chairman of the Prix Galien USA Awards Committee,...

Dr. Lee Merritt believes SARS-CoV-2, the virus behind the Wuhan coronavirus (COVID-19) pandemic, is a genetically engineered bioweapon. "SARS-CoV-2 is a genetically engineered bioweapon, and [...]

Researchers have described prostate cancer cell dynamics at a single-cell resolution throughout the course of the disease, from the first stages to the point of androgen independence, where the tumour no longer responds to hormone restriction therapy.

Throughout the course of the disease, from the first stages to the point of androgen independence, where the tumour ceases to respond to hormone restriction therapy, researchers have characterised prostate cancer cell dynamics at a single-cell resolution.